Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2561 |
Macitentan
马西替坦,ACT-064992 |
Apoptosis; Endothelin Receptor | Apoptosis; GPCR/G Protein |
Macitentan (ACT-064992) 是一种内皮素受体拮抗剂,用于治疗肺动脉高压。 | |||
T6637 |
Resminostat
马西替坦,4SC-201,RAS2410 |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Resminostat (4SC-201) 是一种可口服的HDAC1、HDAC3和HDAC6抑制剂,IC50值分别为 42.5、50.1和71.8 nM,具有潜在抗肿瘤活性。 | |||
T11934 |
Macitentan-d4
Macitentan D4,ACT-064992 D4 |
Endothelin Receptor | GPCR/G Protein |
Macitentan-d4 (ACT-064992 D4) 是一种 Macitentan 氘代物,可被当作非多肽 ETA 和 ETB (内皮素受体)双拮抗剂。Macitentan-d4 比 Macitentan 毒性更低,半衰期更长,可用于研究由内皮素受体介导介导的疾病。 | |||
T11935 |
Macitentan (n-butyl analogue)
|
Others | Others |
Macitentan n-butyl analogue, a derivative of Macitentan, functions as an orally active dual antagonist targeting both endothelin ETA and ETB receptors. This compound shows promise for treating idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), leveraging its non-peptide structure for potential therapeutic applications. |